InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-2.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by BAY CITY CAPITAL LLC. Insider active across 3 companies, notably Xilio Therapeutics, Inc.. Cumulatively, 4 disclosures have been published. Breakdown: 2 buys · 0 sell. History available since 3 December 2021. The latest transaction was disclosed on 3 December 2021 (J). Regulator: SEC (Form 4). The full history is free.
Declarations4 total
750,270 shares0Common StockSEC:0000899243-21-047117:0
665,696 sharesCommon StockSEC:0001104659-21-130027:0
545,166 sharesCommon Stock, par value $0.0001 per shareSEC:0001209191-16-090962:0
Ideal exit: 8 Oct 2016 (T+270)
10,389 sharesCommon Stock, par value $0.0001 per shareSEC:0001209191-16-090962:1
Ideal exit: 8 Oct 2016 (T+270)
4 of 4 declarations
About BAY CITY CAPITAL LLC
BAY CITY CAPITAL LLC is a declarant linked to Madrigal Pharmaceuticals, INC., Xilio Therapeutics, Inc. and Epizyme, Inc., where it is listed as a 10% Owner. The record shows 6 filings in total, and across the 6 sampled filings, the period runs from 2016-01-12 to 2021-12-07, with buy and sell amounts shown as EUR 0.
